EUVIMEDEUVIMED entdecken
Crossref

Predicting potassium trajectories for risk monitoring in outpatients with heart failure, diabetes mellitus or chronic kidney disease

Camilo Scherkl iD, Jacob Grytzka, Marietta Rottenkolber, Tobias Dreischulte, Hanna M Seidling iD, David Czock iD, Andreas Groll, Andreas D Meid iD

British Journal of Clinical Pharmacology · 2026

DOI: 10.1002/bcp.70250 ↗

Kurz gefasst

Fachartikel in der Zeitschrift British Journal of Clinical Pharmacology, 2026. Verfasst von Camilo Scherkl und 7 weiteren Autor:innen. Beteiligte Einrichtung: Internal Medicine IX: Department of Clinical Pharmacology and Pharmacoepidemiology, Heidelberg University, Medical Faculty/Heidelberg University Hosp…. Hauptthemen laut MEDLINE: Heart Failure, Potassium, Renal Insufficiency, Chronic, Diabetes Mellitus. Die Arbeit nennt 37 Literaturangaben. Gefördert von: Deutsche Forschungsgemeinschaft, Research Foundation, ASCRS Research Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aim

To develop a dynamic prediction model for potassium concentration in the outpatient sector for patients with heart failure (HF), chronic kidney disease (CKD) and/or diabetes mellitus (DM).

Methods

We used administrative claims data from Scotland collected at the Tayside Health Informatics Centre and selected patients between 1 January and 30 June 2020 with underlying conditions of HF, CKD and/or DM. The follow‐up time of each patient was divided into assessment periods to predict a patient's maximum potassium value within the next 4 weeks (prediction periods). Three linear mixed‐effect models were fitted and model performance was assessed using root‐mean‐squared‐error (RMSE), mean absolute error (MAE) and mean squared error (MSE).

Results

Among 5918 patients with a mean age of 76.2 years, a median of 17.0 potassium concentrations were measured per patient corresponding with 1.71 measurements per assessment period. In total, we predicted 5478 maximum potassium values. The final model performed with a RMSE of 0.52, MAE of 0.39, MSE of 0.27 and no apparent trends in the residuals over time. Prediction was more accurate within the potassium reference range and tended to underestimate extremely high and overestimate low observations. Among the strongest predictors were newly acquired acute kidney injury, last measured potassium and use of low ceiling and high ceiling diuretics.

Conclusion

We propose a blueprint of a decision support tool which predicts potassium concentration longitudinally by updating the predictions based on accumulating data. Our findings demonstrate that dynamically reassessing predictors can aid in estimating potassium levels over multiple months with reasonable accuracy in the outpatient setting.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Heart FailurePotassiumRenal Insufficiency, ChronicDiabetes MellitusHyperkalemiaHumansMaleFemaleAgedOutpatientsScotlandAged, 80 and overMiddle AgedRisk Assessment

Stichwörter der Autor:innen

chronic kidney diseasediabetes mellitusheart failurehyperkalaemiaoutpatientspotassiumprediction model

Substanzen

Potassium

Autor:innen und Institutionen

  • Internal Medicine IX: Department of Clinical Pharmacology and Pharmacoepidemiology, Heidelberg University, Medical Faculty/Heidelberg University Hospital, Heidelberg, Germany.
  • Department of Statistics, TU Dortmund University, Dortmund, Germany.
  • Institute of General Practice and Family Medicine, University Hospital, LMU Munich, Munich, Germany.
  • Internal Medicine IX: Department of Clinical Pharmacology and Pharmacoepidemiology, Cooperation Unit Clinical Pharmacy, Heidelberg University, Medical Faculty Heidelberg/Heidelberg University Hospital, Heidelberg, Germa…

ORCID-Profile: Camilo Scherkl, Hanna M Seidling, David Czock, Andreas D Meid

Förderung

  • Deutsche Forschungsgemeinschaft
  • Research Foundation
  • ASCRS Research Foundation

Zitieren

APA

Scherkl, C., Grytzka, J., Rottenkolber, M., Dreischulte, T., Seidling, H. M., Czock, D., Groll, A., & Meid, A. D. (2026). Predicting potassium trajectories for risk monitoring in outpatients with heart failure, diabetes mellitus or chronic kidney disease. British Journal of Clinical Pharmacology. https://doi.org/10.1002/bcp.70250

Vancouver

Scherkl C, Grytzka J, Rottenkolber M, Dreischulte T, Seidling HM, Czock D, et al. Predicting potassium trajectories for risk monitoring in outpatients with heart failure, diabetes mellitus or chronic kidney disease. British Journal of Clinical Pharmacology. 2026. doi:10.1002/bcp.70250

BibTeX
@article{Scherkl2026,
  author = {Scherkl, Camilo and Grytzka, Jacob and Rottenkolber, Marietta and Dreischulte, Tobias and Seidling, Hanna M and Czock, David and Groll, Andreas and Meid, Andreas D},
  title = {Predicting potassium trajectories for risk monitoring in outpatients with heart failure, diabetes mellitus or chronic kidney disease},
  journal = {British Journal of Clinical Pharmacology},
  year = {2026},
  doi = {10.1002/bcp.70250}
}
Kostenlos starten →